{"transactions":[{"id":673694,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2976,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2976},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673693,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673692,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each outstanding restricted stock unit (a \"Company RSU\"), whether or not vested, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the Merger Consideration, multiplied by (y) the total number of shares subject to such Company RSU immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673691,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":17.15,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673690,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":29.66,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673689,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":323000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":7.54,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":323000},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673688,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":17.25,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673687,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":43,"exercise_date":"2026-01-17","expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":2999},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673686,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":991.5,"exercise_date":"2025-04-09","expiration_date":"2031-04-09","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673685,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":364.5,"exercise_date":"2024-03-23","expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":2999},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673684,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":421,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each unexercised and outstanding option to purchase shares of Common Stock (a \"Company Option\"), whether or not vested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right of the holder to receive (i) (subject to any applicable withholding taxes) a lump-sum cash payment equal to (x) the excess (if any) of (a) the Merger Consideration over (b) the per share exercise price subject to such Company Option, multiplied by (y) the total number of shares subject to such Company Option immediately prior to the effective time of the Merger.  At the effective time of the Merger, each Company Option that is then outstanding and unexercised, whether or not vested and which has a per share exercise price that is equal to or greater than the Merger Consideration, shall be cancelled with no consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":31,"exercise_date":"2024-03-24","expiration_date":"2030-03-29","underlying":"Common Stock","underlying_shares":421},"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":673683,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-27T20:28:56.000Z","date":"2026-08-27","kind":"other","planned":false,"acquired":false,"shares":42600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated July 26, 2026 (the \"Merger Agreement\"), by and among Forte Biosciences, Inc. (\"Company\"), argenx BV (\"Parent\"), and Avena Merger Sub Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), the shares of common stock of Company that were tendered to Purchaser prior to the expiration time of the offer were exchanged for $77.00 per share (\"Merger Consideration\"), net to the seller in cash, without interest, subject to any required withholding tax. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into Company (the \"Merger\"), with Company surviving the Merger as a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001339375-26-000011","document":"form4-08272026_080850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000011/form4-08272026_080850.xml","form_type":"4"}},{"id":714982,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-07-06T20:04:54.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":750,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001339375-26-000010","document":"form4-07062026_080743.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000010/form4-07062026_080743.xml","form_type":"4"}},{"id":714981,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T20:04:54.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":134,"price":21.32,"value":2856.88,"ownership":{"direct":true},"balance_after":42600,"source":{"system":"sec-edgar","filing":"0001339375-26-000010","document":"form4-07062026_080743.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000010/form4-07062026_080743.xml","form_type":"4"}},{"id":714980,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T20:04:54.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 377 shares of Common Stock acquired July 1, 2026 under the Issuer's 2017 Employee Stock Purchase Plan."}],"balance_after":42734,"source":{"system":"sec-edgar","filing":"0001339375-26-000010","document":"form4-07062026_080743.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000010/form4-07062026_080743.xml","form_type":"4"}},{"id":733871,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T20:55:43.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 16, 2026."}],"balance_after":22000,"derivative":{"exercise_price":17.15,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001339375-26-000008","document":"form4-06172026_080639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000008/form4-06172026_080639.xml","form_type":"4"}},{"id":816099,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T20:02:18.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":1125,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001339375-26-000006","document":"form4-04032026_080413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000006/form4-04032026_080413.xml","form_type":"4"}},{"id":816098,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T20:02:18.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":134,"price":24.86,"value":3331.24,"ownership":{"direct":true},"balance_after":41982,"source":{"system":"sec-edgar","filing":"0001339375-26-000006","document":"form4-04032026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000006/form4-04032026_080413.xml","form_type":"4"}},{"id":816097,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T20:02:18.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":42116,"source":{"system":"sec-edgar","filing":"0001339375-26-000006","document":"form4-04032026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000006/form4-04032026_080413.xml","form_type":"4"}},{"id":940010,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-13T21:12:23.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one fourth (1/4th) of the total RSUs subject to the award shall vest annually on the anniversary of Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one fourth (1/4th) of the total RSUs subject to the award shall vest annually on the anniversary of Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001339375-26-000004","document":"form4-01132026_090120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000004/form4-01132026_090120.xml","form_type":"4"}},{"id":940009,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-13T21:12:23.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2026."}],"balance_after":90000,"derivative":{"exercise_price":29.66,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001339375-26-000004","document":"form4-01132026_090120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000004/form4-01132026_090120.xml","form_type":"4"}},{"id":955096,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-02T21:04:43.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001339375-26-000002","document":"form4-01022026_090140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000002/form4-01022026_090140.xml","form_type":"4"}},{"id":955095,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-02T21:04:43.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":154,"price":27.27,"value":4199.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 1, 2026, the Reporting Person's RSUs vested. The closing price of the Issuer's Common Stock on December 31, 2025 was the settlement price used to calculate the shares withheld."}],"balance_after":41741,"source":{"system":"sec-edgar","filing":"0001339375-26-000002","document":"form4-01022026_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000002/form4-01022026_090140.xml","form_type":"4"}},{"id":955094,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-02T21:04:43.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":41895,"source":{"system":"sec-edgar","filing":"0001339375-26-000002","document":"form4-01022026_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000002/form4-01022026_090140.xml","form_type":"4"}},{"id":955093,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-02T21:04:43.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":9680,"price":26.3257,"value":254832.776,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 9,680 shares purchased in the price range of $26.2243 to $26.59 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":41520,"source":{"system":"sec-edgar","filing":"0001339375-26-000002","document":"form4-01022026_090140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937526000002/form4-01022026_090140.xml","form_type":"4"}},{"id":1027034,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:10:10.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":1875,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001339375-25-000003","document":"form4-10022025_081004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937525000003/form4-10022025_081004.xml","form_type":"4"}},{"id":1027033,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T20:10:10.000Z","date":"2025-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":134,"price":14.52,"value":1945.68,"ownership":{"direct":true},"balance_after":31840,"source":{"system":"sec-edgar","filing":"0001339375-25-000003","document":"form4-10022025_081004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937525000003/form4-10022025_081004.xml","form_type":"4"}},{"id":1027032,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T20:10:10.000Z","date":"2025-10-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":31974,"source":{"system":"sec-edgar","filing":"0001339375-25-000003","document":"form4-10022025_081004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000133937525000003/form4-10022025_081004.xml","form_type":"4"}},{"id":1092167,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-07-03T20:22:07.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":2250,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-25-019322","document":"form4-07032025_080704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925019322/form4-07032025_080704.xml","form_type":"4"}},{"id":1092166,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-03T20:22:07.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":134,"price":12.44,"value":1666.96,"ownership":{"direct":true},"balance_after":31599,"source":{"system":"sec-edgar","filing":"0001415889-25-019322","document":"form4-07032025_080704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925019322/form4-07032025_080704.xml","form_type":"4"}},{"id":1092165,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-03T20:22:07.000Z","date":"2025-07-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 140 shares of Common Stock acquired July 1, 2025 under Forte Biosciences, Inc.'s 2017 Employee Stock Purchase Plan."}],"balance_after":31733,"source":{"system":"sec-edgar","filing":"0001415889-25-019322","document":"form4-07032025_080704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925019322/form4-07032025_080704.xml","form_type":"4"}},{"id":1183160,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:03:05.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":2625,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-25-009697","document":"form4-04022025_090400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925009697/form4-04022025_090400.xml","form_type":"4"}},{"id":1183159,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-02T21:03:05.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":154,"price":7.43,"value":1144.22,"ownership":{"direct":true},"balance_after":31218,"source":{"system":"sec-edgar","filing":"0001415889-25-009697","document":"form4-04022025_090400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925009697/form4-04022025_090400.xml","form_type":"4"}},{"id":1183158,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-02T21:03:05.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":31372,"source":{"system":"sec-edgar","filing":"0001415889-25-009697","document":"form4-04022025_090400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925009697/form4-04022025_090400.xml","form_type":"4"}},{"id":1194555,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-21T20:40:27.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":323000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the three (3) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 1, 2025."}],"balance_after":323000,"derivative":{"exercise_price":7.54,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":323000},"source":{"system":"sec-edgar","filing":"0001415889-25-008779","document":"form4-03212025_080324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925008779/form4-03212025_080324.xml","form_type":"4"}},{"id":1318532,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-02T22:10:05.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-25-000142","document":"form4-01022025_100101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925000142/form4-01022025_100101.xml","form_type":"4"}},{"id":1318531,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-02T22:10:05.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":154,"price":22.71,"value":3497.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2025, the Reporting Person's RSUs vested. The closing price of the Issuer's Common Stock on December 31, 2024 was the settlement price used to calculate the shares withheld."}],"balance_after":30997,"source":{"system":"sec-edgar","filing":"0001415889-25-000142","document":"form4-01022025_100101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925000142/form4-01022025_100101.xml","form_type":"4"}},{"id":1318530,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-02T22:10:05.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."}],"balance_after":31151,"source":{"system":"sec-edgar","filing":"0001415889-25-000142","document":"form4-01022025_100101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588925000142/form4-01022025_100101.xml","form_type":"4"}},{"id":1354095,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-22T22:45:42.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":22514,"price":5.552,"value":124997.728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 19, 2024, the Issuer and the Reporting Person entered into a Securities Purchase Agreement (the \"SPA\"), pursuant to which the Reporting Person purchased 22,514 shares of common stock from the Issuer in a private placement in reliance upon the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. The transaction contemplated by the SPA closed on November 21, 2024."}],"balance_after":30776,"source":{"system":"sec-edgar","filing":"0001415889-24-027557","document":"form4-11222024_101137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924027557/form4-11222024_101137.xml","form_type":"4"}},{"id":1394248,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-10-02T22:21:06.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported number of securities has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effected on August 28, 2024."}],"balance_after":3375,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001415889-24-024495","document":"form4-10022024_101001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924024495/form4-10022024_101001.xml","form_type":"4"}},{"id":1394247,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T22:21:06.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":133,"price":5.16,"value":686.28,"ownership":{"direct":true},"balance_after":8262,"source":{"system":"sec-edgar","filing":"0001415889-24-024495","document":"form4-10022024_101001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924024495/form4-10022024_101001.xml","form_type":"4"}},{"id":1394246,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T22:21:06.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported number of securities has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effected on August 28, 2024."}],"balance_after":8395,"source":{"system":"sec-edgar","filing":"0001415889-24-024495","document":"form4-10022024_101001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924024495/form4-10022024_101001.xml","form_type":"4"}},{"id":1459684,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-07-03T16:18:01.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":93750,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001415889-24-019123","document":"form4-07032024_040758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924019123/form4-07032024_040758.xml","form_type":"4"}},{"id":1459683,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-03T16:18:01.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3345,"price":0.546,"value":1826.37,"ownership":{"direct":true},"balance_after":200504,"source":{"system":"sec-edgar","filing":"0001415889-24-019123","document":"form4-07032024_040758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924019123/form4-07032024_040758.xml","form_type":"4"}},{"id":1459682,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-03T16:18:01.000Z","date":"2024-07-01","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":203849,"source":{"system":"sec-edgar","filing":"0001415889-24-019123","document":"form4-07032024_040758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924019123/form4-07032024_040758.xml","form_type":"4"}},{"id":1553268,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T22:32:01.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":103125,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001415889-24-009859","document":"form4-04022024_100453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009859/form4-04022024_100453.xml","form_type":"4"}},{"id":1553267,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-02T22:32:01.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3345,"price":0.7075,"value":2366.5875,"ownership":{"direct":true},"balance_after":194474,"source":{"system":"sec-edgar","filing":"0001415889-24-009859","document":"form4-04022024_100453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009859/form4-04022024_100453.xml","form_type":"4"}},{"id":1553266,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-02T22:32:01.000Z","date":"2024-04-01","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":197819,"source":{"system":"sec-edgar","filing":"0001415889-24-009859","document":"form4-04022024_100453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009859/form4-04022024_100453.xml","form_type":"4"}},{"id":1561807,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-25T20:08:39.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the amended and restated 2021 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean March 21, 2024."}],"balance_after":350000,"derivative":{"exercise_price":0.69,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001415889-24-009031","document":"form4-03252024_080334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000141588924009031/form4-03252024_080334.xml","form_type":"4"}},{"id":1691886,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:02:21.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-24-000319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000319/doc4.xml","form_type":"4"}},{"id":1691885,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T21:02:21.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3841,"price":0.8217,"value":3156.1497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 1, 2024, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on December 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":188444,"source":{"system":"sec-edgar","filing":"0001209191-24-000319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000319/doc4.xml","form_type":"4"}},{"id":1691884,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T21:02:21.000Z","date":"2024-01-01","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":192285,"source":{"system":"sec-edgar","filing":"0001209191-24-000319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919124000319/doc4.xml","form_type":"4"}},{"id":1767180,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-03T20:27:24.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":121875,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-23-051480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051480/doc4.xml","form_type":"4"}},{"id":1767179,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:27:24.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3241,"price":0.662,"value":2145.542,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on September 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":182910,"source":{"system":"sec-edgar","filing":"0001209191-23-051480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051480/doc4.xml","form_type":"4"}},{"id":1767178,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:27:24.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":186151,"source":{"system":"sec-edgar","filing":"0001209191-23-051480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123051480/doc4.xml","form_type":"4"}},{"id":1817767,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-02T21:57:13.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":148514,"price":1.01,"value":149999.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,500 shares of Common Stock acquired July 3, 2023 under Forte Biosciences, Inc.'s 2017 Employee Stock Purchase Plan."}],"balance_after":176776,"source":{"system":"sec-edgar","filing":"0001209191-23-044281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123044281/doc4.xml","form_type":"4"}},{"id":1835853,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:06:20.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":131250,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-23-040968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040968/doc4.xml","form_type":"4"}},{"id":1835852,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:06:20.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3241,"price":1.04,"value":3370.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on June 30, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":24762,"source":{"system":"sec-edgar","filing":"0001209191-23-040968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040968/doc4.xml","form_type":"4"}},{"id":1835851,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:06:20.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."}],"balance_after":28003,"source":{"system":"sec-edgar","filing":"0001209191-23-040968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123040968/doc4.xml","form_type":"4"}},{"id":1927737,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:18:30.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":140625,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-23-023079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023079/doc4.xml","form_type":"4"}},{"id":1927736,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:18:30.000Z","date":"2023-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3241,"price":1.01,"value":3273.41,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On April 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on March 31, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":18628,"source":{"system":"sec-edgar","filing":"0001209191-23-023079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023079/doc4.xml","form_type":"4"}},{"id":1927735,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:18:30.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,429 shares of Common Stock acquired January 3, 2022 under Forte Biosciences, Inc.'s 2017 Employee Stock Purchase Plan."}],"balance_after":21869,"source":{"system":"sec-edgar","filing":"0001209191-23-023079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123023079/doc4.xml","form_type":"4"}},{"id":1990182,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T01:17:11.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, \"Quarterly Vesting Date\" with respect to any calendar year means January 1, April 1, July 1, and October 1."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-013452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000120919123013452/doc4.xml","form_type":"4"}},{"id":2433635,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T01:39:52.000Z","date":"2022-01-17","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean January 17, 2022."}],"balance_after":75000,"derivative":{"exercise_price":1.72,"expiration_date":"2032-01-17","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-22-002264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924322002264/doc4.xml","form_type":"4"}},{"id":2577132,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-07T20:09:58.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":3516,"price":4.27,"value":15013.32,"ownership":{"direct":true},"balance_after":11065,"source":{"system":"sec-edgar","filing":"0000899243-21-035246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321035246/doc4.xml","form_type":"4"}},{"id":2577131,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-07T20:09:58.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":21484,"price":4.24,"value":91092.16,"ownership":{"direct":true},"balance_after":14581,"source":{"system":"sec-edgar","filing":"0000899243-21-035246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321035246/doc4.xml","form_type":"4"}},{"id":2750334,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-13T22:04:04.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's Continuous Service (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean April 9, 2021."}],"balance_after":42500,"derivative":{"exercise_price":39.66,"expiration_date":"2031-04-09","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0000899243-21-015642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924321015642/doc4.xml","form_type":"4"}},{"id":3096528,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-01T00:07:40.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date.  \"Vesting Commencement Date\" shall mean March 23, 2020."}],"balance_after":75000,"derivative":{"exercise_price":14.58,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-20-018041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924320018041/doc4.xml","form_type":"4"}},{"id":3096527,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-01T00:07:40.000Z","date":"2020-06-29","kind":"purchase","acquired":true,"shares":2000,"price":14.11,"value":28220.0,"ownership":{"direct":true},"balance_after":36065,"source":{"system":"sec-edgar","filing":"0000899243-20-018041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924320018041/doc4.xml","form_type":"4"}},{"id":3096526,"issuer":{"id":9529,"kind":"organization","name":"Forte Biosciences, Inc."},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-07-01T00:07:40.000Z","date":"2020-06-26","kind":"purchase","acquired":true,"shares":4700,"price":14.516,"value":68225.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 4,700 shares purchased in the price range of $14.25 to $14.75 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":34065,"source":{"system":"sec-edgar","filing":"0000899243-20-018041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419041/000089924320018041/doc4.xml","form_type":"4"}},{"id":3363108,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-21T21:05:18.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on March 8, 2018 and vest ratably over a four-year period."}],"balance_after":18750,"derivative":{"exercise_price":9.85,"expiration_date":"2028-03-08","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-19-057590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919119057590/doc4.xml","form_type":"4"}},{"id":3363107,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-21T21:05:18.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":6250,"price":9.85,"value":61562.5,"ownership":{"direct":true},"balance_after":9050,"source":{"system":"sec-edgar","filing":"0001209191-19-057590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919119057590/doc4.xml","form_type":"4"}},{"id":3487819,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T21:24:44.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 1, 2019 and vest ratably over a four-year period."}],"balance_after":25000,"derivative":{"exercise_price":31.42,"expiration_date":"2029-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-037449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919119037449/doc4.xml","form_type":"4"}},{"id":3580207,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-26T01:07:49.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on March 22, 2019 and vest ratably over a four-year period."}],"balance_after":25000,"derivative":{"exercise_price":25.02,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-021266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919119021266/doc4.xml","form_type":"4"}},{"id":3918854,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-24T21:28:17.000Z","date":"2018-03-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on March 8, 2018 and vest ratably over a four-year period."}],"balance_after":25000,"derivative":{"exercise_price":9.85,"expiration_date":"2028-03-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-033088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919118033088/doc4.xml","form_type":"4"}},{"id":3918853,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":19058,"kind":"person","name":"Riley Antony A","position":1,"cik":"0001339375","reported_name":"Riley Antony A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-24T21:28:17.000Z","date":"2018-05-22","kind":"purchase","acquired":true,"shares":2800,"price":10.75,"value":30100.0,"ownership":{"direct":true},"balance_after":2800,"source":{"system":"sec-edgar","filing":"0001209191-18-033088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000120919118033088/doc4.xml","form_type":"4"}}]}